FeaturesSignalPricingFounders
Log inGet started free
MB

Melissa Byrne

Venture CapitalActive

Investment Analyst at Brandon Capital Partners Pty Ltd

Melbourne, AustraliaFounded 2013brandoncapital.vc/team_member/melissa-byrne-2/
24
Investments
0
Exits
—
AUM
0.0%
Exit Rate

Get contact info, warm intros & fit scores

Sign up to unlock emails, Signal intro paths, and personalized fit analysis for Melissa Byrne.

Get started free

Investment Thesis & Strategy

Melissa Byrne, as an Investment Analyst at Brandon Capital Partners, invests in various stages of biotech, edtech, health & hospital services, medical devices, and pharmaceutical companies. They likely seek innovative companies with strong growth potential within these specific sectors.

Investment Activity

Deals per year over the last 4 years

1
2019
4
2020
4
2021
3
2022

Portfolio Companies

Selected investments from their portfolio of 24 companies

M
MecRx
Biotech · Seed, 2022
Active
M
MetaBloQ
Biotech · Seed, 2022
Active
C
Cardiora
Biotech · Seed, 2022
Active
P
Protego Medical
Healthcare · Seed, 2021
Active
Q
QUE Oncology
Biotech · Seed, 2021
Active
S
Solvanix
Biotech · Seed, 2021
Active
H
Heart Metabolics
Biotech · Seed, 2021
Active
M
Myricx Pharma
Biotech · Seed, 2020
Active
G
G I Therapies
Biotech · Seed, 2020
Active
O
OccuRx
Biotech · Seed, 2020
Active
D
Denteric
Biotech · Seed, 2020
Active
O
Okogen
Biotech · Seed, 2019
Active

Frequently Asked Questions

Melissa Byrne focuses on Seed stage investments.

Related Investors

Square Peg Capital

Melbourne, Australia · 80 deals

Starfish Ventures

Melbourne, Australia · 49 deals

Future Fund

Melbourne, Australia · 36 deals

SEEK

Melbourne, Australia · 32 deals

Brandon Capital Partners

Melbourne, Australia · 28 deals

Giant Leap Fund

Melbourne, Australia · 15 deals